These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32283900)

  • 21. Generation of Chimeric "ABS Nanohemostat" Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model.
    Huri E; Beyazit Y; Mammadov R; Toksoz S; Tekinay AB; Guler MO; Ustun H; Kekilli M; Dadali M; Celik T; Astarci M; Haznedaroglu IC
    Int J Biomater; 2013; 2013():949460. PubMed ID: 23509463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids.
    Koluman A; Akar N; Malkan UY; Haznedaroglu IC
    Biomed Res Int; 2016; 2016():8957820. PubMed ID: 26925418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases.
    Koluman A; Akar N; Haznedaroğlu İC
    Turk J Haematol; 2017 Mar; 34(1):93-98. PubMed ID: 26377624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model.
    Bilgili H; Kosar A; Kurt M; Onal IK; Goker H; Captug O; Shorbagi A; Turgut M; Kekilli M; Kurt OK; Kirazli S; Aksu S; Haznedaroglu IC
    Med Princ Pract; 2009; 18(3):165-9. PubMed ID: 19349716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, Ankaferd Blood Stopper, on vascular tissue in a rat aortic bleeding model.
    Kandemir O; Buyukates M; Kandemir NO; Aktunc E; Gul AE; Gul S; Turan SA
    J Cardiothorac Surg; 2010 Nov; 5():110. PubMed ID: 21073754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical Ankaferd hemostat application for the management of oral cavity bleedings in children with hemorrhagic diathesis.
    Leblebisatan G; Bay A; Karakus SC; Kekilli M; Haznedaroglu IC
    Blood Coagul Fibrinolysis; 2012 Sep; 23(6):494-7. PubMed ID: 22576286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of microporous polysaccharide hemospheres and Ankaferd Blood Stopper in a rabbit epistaxis model.
    Yurttas V; Sereflican M; Terzi EH; Ozyalvaçlı G; Kazaz H
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):933-8. PubMed ID: 26100031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tandem oral, rectal, and nasal administrations of Ankaferd Blood Stopper to control profuse bleeding leading to hemodynamic instability.
    Kurt M; Oztas E; Kuran S; Onal IK; Kekilli M; Haznedaroglu IC
    Am J Emerg Med; 2009 Jun; 27(5):631.e1-2. PubMed ID: 19497484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of Ankaferd® Blood Stopper on transcription factors in HUVEC and the erythrocyte protein profile.
    Yılmaz E; Güleç Ş; Torun D; Haznedaroğlu İC; Akar N
    Turk J Haematol; 2011 Dec; 28(4):276-85. PubMed ID: 27264584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First clinical experience of Ankaferd BloodStopper as a hemostatic agent in partial nephrectomy.
    Huri E; Akgül T; Ayyildiz A; Bağcioğlu M; Germiyanoğlu C
    Kaohsiung J Med Sci; 2010 Sep; 26(9):493-5. PubMed ID: 20837346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the plant-based hemostatic agent Ankaferd Blood Stopper® on the biocompatibility of mineral trioxide aggregate.
    Dinçol ME; Ozbas H; Yılmaz B; Ersev H; Gokyay S; Olgac V
    BMC Oral Health; 2016 Oct; 16(1):111. PubMed ID: 27724900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effectiveness of Ankaferd Blood Stopper in the Management of Traumatic Bleeding.
    Koyuncu N
    Adv Ther; 2019 May; 36(5):1143-1149. PubMed ID: 30900196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible protease-activated receptor 1 downregulation mediated by Ankaferd blood stopper inducible with lipopolysaccharides inside the human umbilical vein endothelial cells.
    Karabiyik A; Güleç S; Yilmaz E; Haznedaroglu I; Akar N
    Clin Appl Thromb Hemost; 2011; 17(6):E165-70. PubMed ID: 21406410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine.
    Okay M; Ozturk Y; Haznedaroglu IC
    Clin Appl Thromb Hemost; 2019; 25():1076029618824416. PubMed ID: 30808215
    [No Abstract]   [Full Text] [Related]  

  • 35. Prospective, randomized, controlled clinical trial of Ankaferd Blood Stopper in patients with acute anterior epistaxis.
    Meric Teker A; Korkut AY; Kahya V; Gedikli O
    Eur Arch Otorhinolaryngol; 2010 Sep; 267(9):1377-81. PubMed ID: 20155359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the hemostatic efficiency of Ankaferd Blood Stopper and fibrin glue on a liver laceration model in rats].
    Akarsu C; Kalaycı MU; Yavuz E; Ozkara S; Gökçek B; Ozdenkaya Y; Yalçın O
    Ulus Travma Acil Cerrahi Derg; 2011 Jul; 17(4):308-12. PubMed ID: 21935827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper.
    Simsek C; Selek S; Koca M; Haznedaroglu IC
    SAGE Open Med; 2017; 5():2050312117722569. PubMed ID: 28839937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures.
    Kurt M; Onal I; Akdogan M; Kekilli M; Arhan M; Sayilir A; Oztas E; Haznedaroglu I
    Can J Gastroenterol; 2010 Jun; 24(6):380-4. PubMed ID: 20559581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antioxidant and antimutagenic activities of Ankaferd blood stopper,a natural hemostatic agent used in dentistry.
    Uğur A; Saraç N; Çankal DA; Özle M
    Turk J Med Sci; 2016 Apr; 46(3):657-63. PubMed ID: 27513238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ankaferd blood stopper on hemostasis and histopathological score in experimental liver injury.
    Kalayci MU; Soylu A; Eroglu HE; Kubilay D; Sancak B; Ugurluoglu C; Ercin U; Koca Y; Karatepe O
    Bratisl Lek Listy; 2010; 111(4):183-8. PubMed ID: 20586143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.